VanEck Associates’s Axcelis ACLS Stock Holding History

VanEck Associates’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-23,751	Closed	-$2.14M	–	1387
2024 Q3	$2.14M	Buy	23,751 +6,786	+40%	+$794K	﹤0.01%	906
2024 Q2	$2.41M	Buy	16,965 +3,227	+23%	+$372K	﹤0.01%	826
2024 Q1	$1.53M	Buy	13,738 +3,674	+37%	+$438K	﹤0.01%	926
2023 Q4	$1.3M	Buy	10,064 +2,877	+40%	+$397K	﹤0.01%	913
2023 Q3	$1.17M	Buy	7,187 +2,154	+43%	+$379K	﹤0.01%	858
2023 Q2	$923K	Buy	+5,033	New	+$725K	﹤0.01%	885

Other funds holding ACLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

VanEck Associates's ACLS Position: Q4 2024 in Review

VanEck Associates sold out of Axcelis (ACLS) in Q4 2024, closing a stake of 23,751 shares — an estimated $2.14M sold.

VanEck Associates first reported a position in ACLS in Q2 2023 and held it in 6 quarters. The position peaked at $2.41M in Q2 2024. 324 funds tracked by Wall St. Rank hold ACLS as of Q4 2024.

VanEck Associates reported no remaining Axcelis position as of Q4 2024 after selling out during the quarter.
VanEck Associates sold 23,751 Axcelis shares in Q4 2024, an estimated $2.14M.
VanEck Associates first reported a position in Axcelis in Q2 2023 and held it in 6 quarters.
VanEck Associates's Axcelis position peaked at $2.41M in Q2 2024.
324 funds tracked by Wall St. Rank held Axcelis as of Q4 2024.

Based on VanEck Associates's 13F filing for Q4 2024, filed 29 Jan 2025.